Skip to main content
. Author manuscript; available in PMC: 2015 Aug 19.
Published in final edited form as: Brain Res. 2014 Jun 28;0:21–28. doi: 10.1016/j.brainres.2014.06.026

Fig. 5.

Fig. 5

Changes in mean arterial pressure (MAP) and heart rate (HR) caused by intra-RVLM acetaldehyde (ACA, 2 μg) in the absence and presence of PD98059 (1 μg, ERK1/2 inhibitor). Values are mean±S.E.M. of 6-10 observations. *P<0.05 vs. “DMSO+ACSF”.